Neurofeedback may reduce chemotherapy-induced neuropathy

In a study that will be presented at the upcoming American Psychosomatic Society annual meeting (9–12 March 2016; Denver, CO, USA), a team of researchers at The University of Texas MD Anderson Cancer Center (TX, USA) have discovered a link between the use of neurofeedback and a decrease in personal experience of chronic pain in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN). The results help to expand knowledge of neuropathic pain and a chemotherapy side effect that affects 71–96% of cancer patients. “Chemotherapy-induced peripheral neuropathy is very common in cancer patients and there is currently only one medication approved to...